K. Sachdev Amit's most recent trade in Vertex Pharmaceuticals, Inc. was a trade of 3,703 Common Stock done at an average price of $479.6 . Disclosure was reported to the exchange on Feb. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 479.61 per share. | 26 Feb 2025 | 3,703 | 68,490 (0%) | 0% | 479.6 | 1,775,996 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 483.28 per share. | 24 Feb 2025 | 2,470 | 72,193 (0%) | 0% | 483.3 | 1,193,702 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.46 per share. | 14 Feb 2025 | 2,139 | 74,663 (0%) | 0% | 463.5 | 991,341 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 6,211 | 76,802 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 467.98 per share. | 10 Feb 2025 | 2,056 | 70,591 (0%) | 0% | 468.0 | 962,167 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 8,210 | 65,533 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 7,114 | 72,647 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2024 | 4,600 | 0 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Sale of securities on an exchange or to another person at price $ 430.94 per share. | 15 May 2024 | 32 | 55,325 (0%) | 0% | 430.9 | 13,790 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Sale of securities on an exchange or to another person at price $ 425.70 per share. | 23 Feb 2024 | 3,004 | 55,325 (0%) | 0% | 425.7 | 1,278,803 | Common Stock |
| Vertex Pharma | K. Sachdev Amit | EVP Chief Patient & Ext Af Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 431.79 per share. | 23 Feb 2024 | 2,469 | 58,329 (0%) | 0% | 431.8 | 1,066,090 | Common Stock |
| Vertex Pharma | Amit Sachdev K. | EVP Chief Patient & Ext Af Off | Sale of securities on an exchange or to another person at price $ 421.77 per share. | 21 Feb 2024 | 3,191 | 60,798 (0%) | 0% | 421.8 | 1,345,868 | Common Stock |
| Vertex Pharma | Amit Sachdev K. | EVP Chief Patient & Ext Af Off | Sale of securities on an exchange or to another person at price $ 420.79 per share. | 16 Feb 2024 | 4,254 | 63,989 (0%) | 0% | 420.8 | 1,790,041 | Common Stock |
| Vertex Pharma | K. Amit Sachdev | EVP Chief Patient & Ext Af Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 424.01 per share. | 16 Feb 2024 | 3,498 | 70,866 (0%) | 0% | 424.0 | 1,483,187 | Common Stock |
| Vertex Pharma | K. Amit Sachdev | EVP Chief Patient & Ext Af Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 420.58 per share. | 16 Feb 2024 | 2,623 | 68,243 (0%) | 0% | 420.6 | 1,103,181 | Common Stock |
| Vertex Pharma | K. Sachdev Amit | EVP Chief Patient & Ext Af Off | Sale of securities on an exchange or to another person at price $ 420.24 per share. | 09 Feb 2024 | 3,222 | 74,364 (0%) | 0% | 420.2 | 1,354,013 | Common Stock |
| Vertex Pharma | K. Amit Sachdev | EVP Chief Patient & Ext Af Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 422.74 per share. | 09 Feb 2024 | 2,022 | 77,586 (0%) | 0% | 422.7 | 854,780 | Common Stock |
| Vertex Pharma | Sachdev Amit K. | EVP Chief Patient & Ext Af Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 7,866 | 72,494 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Sachdev K. Amit | EVP Chief Patient & Ext Af Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 7,114 | 79,608 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP Chief Patient & Ext Af Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 5,814 | 64,628 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 10 Aug 2023 | 10,031 | 58,814 (0%) | 0% | 350 | 3,510,850 | Common Stock |
| Eiger BioPharmaceuticals Inc | Amit K. Sachdev | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.12 per share. | 24 Feb 2023 | 2,468 | 66,518 (0%) | 0% | 289.1 | 713,548 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.85 per share. | 17 Feb 2023 | 3,498 | 68,986 (0%) | 0% | 292.8 | 1,024,389 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 298.26 per share. | 10 Feb 2023 | 4,657 | 72,484 (0%) | 0% | 298.3 | 1,388,997 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 294.33 per share. | 10 Feb 2023 | 2,611 | 77,141 (0%) | 0% | 294.3 | 768,496 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 10,324 | 63,676 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 8,210 | 71,886 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 7,866 | 79,752 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2023 | 1,672 | 11,052 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.86 per share. | 24 Feb 2022 | 7,368 | 48,210 (0%) | 0% | 227.9 | 1,678,872 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 232.51 per share. | 17 Feb 2022 | 3,497 | 55,578 (0%) | 0% | 232.5 | 813,087 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 237.74 per share. | 10 Feb 2022 | 2,491 | 59,075 (0%) | 0% | 237.7 | 592,210 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 11,628 | 53,356 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 9,800 | 41,728 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 8,210 | 61,566 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 187.47 per share. | 15 Nov 2021 | 30 | 31,928 (0%) | 0% | 187.5 | 5,624 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 186.76 per share. | 15 Nov 2021 | 21 | 31,958 (0%) | 0% | 186.8 | 3,922 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 216.41 per share. | 17 May 2021 | 32 | 40,138 (0%) | 0% | 216.4 | 6,925 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 215.62 per share. | 17 May 2021 | 8 | 40,170 (0%) | 0% | 215.6 | 1,725 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 217.20 per share. | 17 May 2021 | 5 | 40,133 (0%) | 0% | 217.2 | 1,086 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.52 per share. | 27 Apr 2021 | 3,884 | 44,017 (0%) | 0% | 86.5 | 336,044 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2021 | 3,884 | 0 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 215.58 per share. | 27 Apr 2021 | 2,346 | 41,671 (0%) | 0% | 215.6 | 505,751 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 216.67 per share. | 27 Apr 2021 | 1,338 | 40,333 (0%) | 0% | 216.7 | 289,904 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 217.69 per share. | 27 Apr 2021 | 200 | 40,133 (0%) | 0% | 217.7 | 43,538 | Common Stock |
| Eiger BioPharmaceuticals Inc | Amit K. Sachdev | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Eiger BioPharmaceuticals Inc | Amit K. Sachdev | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 5,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.57 per share. | 24 Feb 2021 | 2,946 | 43,719 (0%) | 0% | 217.6 | 640,961 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 213.30 per share. | 24 Feb 2021 | 1,460 | 41,337 (0%) | 0% | 213.3 | 311,418 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 211.56 per share. | 24 Feb 2021 | 922 | 42,797 (0%) | 0% | 211.6 | 195,058 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 214.19 per share. | 24 Feb 2021 | 668 | 40,669 (0%) | 0% | 214.2 | 143,079 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 215.56 per share. | 24 Feb 2021 | 336 | 40,333 (0%) | 0% | 215.6 | 72,428 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 216.62 per share. | 24 Feb 2021 | 200 | 40,133 (0%) | 0% | 216.6 | 43,324 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 211.75 per share. | 17 Feb 2021 | 7,613 | 55,929 (0%) | 0% | 211.8 | 1,612,053 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 212.15 per share. | 17 Feb 2021 | 5,800 | 47,465 (0%) | 0% | 212.2 | 1,230,470 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 211.36 per share. | 17 Feb 2021 | 1,500 | 53,265 (0%) | 0% | 211.4 | 317,040 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 210.00 per share. | 17 Feb 2021 | 1,164 | 54,765 (0%) | 0% | 210 | 244,440 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 213.02 per share. | 17 Feb 2021 | 800 | 46,665 (0%) | 0% | 213.0 | 170,416 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 210.43 per share. | 11 Feb 2021 | 3,860 | 64,142 (0%) | 0% | 210.4 | 812,260 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 211.22 per share. | 11 Feb 2021 | 500 | 63,642 (0%) | 0% | 211.2 | 105,610 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 211.98 per share. | 11 Feb 2021 | 100 | 63,542 (0%) | 0% | 212.0 | 21,198 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.16 per share. | 10 Feb 2021 | 2,421 | 68,002 (0%) | 0% | 214.2 | 518,481 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 11,627 | 70,423 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 10,324 | 58,796 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 10,126 | 48,472 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2021 | 3,391 | 7,368 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2020 | 1,941 | 3,884 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.52 per share. | 03 Aug 2020 | 1,941 | 37,044 (0%) | 0% | 86.5 | 167,935 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 279.18 per share. | 03 Aug 2020 | 751 | 35,103 (0%) | 0% | 279.2 | 209,664 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 278.25 per share. | 03 Aug 2020 | 690 | 35,854 (0%) | 0% | 278.3 | 191,993 | Common Stock |
| Vertex Pharma | Amit K. Sachdev | EVP, Chief Patient Officer | Sale of securities on an exchange or to another person at price $ 276.96 per share. | 03 Aug 2020 | 500 | 36,544 (0%) | 0% | 277.0 | 138,480 | Common Stock |